Format

Send to

Choose Destination
Clin Microbiol Infect. 2004 Jul;10(7):659-62.

High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.

Author information

1
Institute of Medical Microbiology, National Reference Centre for Streptococci, University Hospital, Aachen, Germany. Reinert@rwth-aachen.de

Abstract

An isolate of Streptococcus pyogenes isolated from a 63-year-old woman with a serious wound infection was found to be highly resistant to fluoroquinolones (levofloxacin MIC > or = 32 mg/L). DNA amplification and sequencing revealed a serine-81 to phenylalanine substitution in gyrA and three substitutions in parC: serine-79 to phenylalanine, aspartic acid-91 to asparagine, and serine-140 to proline. To our knowledge, this is the first report from a European country of a clinical isolate of S. pyogenes with high-level fluoroquinolone resistance.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center